Home exercise program using mobile technology for patients with a HeartMate 3 device
Official title: Home-Based Exercise Program Using Mobile Technology After Left Ventricular Assist Device Implantation
Run by University of Pennsylvania · NCT06291922 · Data updated 2026-11-12
This study is testing whether a home exercise program using mobile technology can help people with a HeartMate 3 device feel stronger and improve their quality of life compared to those who just get regular care.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | University of Pennsylvania Academic / other |
| Locations | 4 sites (Detroit, Michigan and 3 other locations) |
| Status | Recruiting |
| Started | August 14, 2024 |
| Main results expected | June 30, 2028 |
| Study ends | June 30, 2028 |
| Registry record updated | October 7, 2026 |
| Trial ID | NCT06291922 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older who have recently received a HeartMate 3 LVAD and can ambulate independently.
✕Probably not a fit
Patients with major comorbidities or limitations that interfere with exercise training, such as significant orthopedic or neurologic issues, may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial evaluates the effects of a home-based exercise program utilizing mobile technology on patients who have recently received a HeartMate 3 left ventricular assist device (LVAD). Participants will be randomized into two groups: one receiving an individualized exercise intervention and the other receiving usual care. The study will assess various outcomes including physical activity, frailty, muscle mass, and quality of life through baseline measurements and ongoing monitoring using activity tracking devices. The intervention group will receive tailored exercise prescriptions and support, while the control group will be encouraged to increase their activity levels with standard care.
Why it matters
Potential benefit: If successful, this program could significantly improve physical activity levels, muscle mass, and overall quality of life for patients with LVADs.
How similar studies have gone: Previous studies have shown positive outcomes with exercise interventions in heart failure patients, suggesting potential success for this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. ≥ 18 years of age 2. Newly implanted with a HeartMate 3™ LVAD for the first time 3. Able to ambulate independently (with or without the use of an assistive device) 4. Owns a smartphone with Internet connection 5. Patient will be discharged home with LVAD or patient will be living at home with LVAD within 45 days of index discharge Exclusion Criteria: 1\. Major comorbidities or limitations that may interfere with exercise training (including significant orthopedic/neurologic limitations, decompensated heart failure, uncontrolled arrhythmias, unstable angina)
Where it's running
-
Henry Ford Health
Detroit, Michigan, United States Recruiting -
Cleveland Clinic Foundation
Cleveland, Ohio, United States Recruiting -
University of Pennsylvania
Philadelphia, Pennsylvania, United States Recruiting -
University of Utah Health
Salt Lake City, Utah, United States Recruiting
Study contacts
- Principal investigator: Himabindu Vidula, MD — University of Pennsylvania
- Study coordinator: Clinical Research Coordinator
- Email: sadie.butcher@pennmedicine.upenn.edu
- Phone: 215-615-4480
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using Apple Watch data to predict heart failure outcomes
This study is testing if data from Apple Watches can help predict heart failure problems and the chances of needing to go back to the hospital for patients with heart failure.
-
Comparing Aortix Device to Diuretics for Acute Heart Failure
This study is testing whether the Aortix device can help people with acute heart failure who aren't responding to diuretics feel better compared to standard treatment.
-
Myocardial Energetics Across Cardiovascular Disease Spectrum Using 31P-MRS
Researchers are testing whether phosphorus-31 magnetic resonance spectroscopy (31P-MRS) can map heart energy metabolism across healthy people and patients with various heart conditions.
-
Tailored digital support to cut sedentary time in long-term cardiac rehab
In adults in a long-term cardiac rehabilitation program, this study tests whether a personalized behavioural program with digital tools can reduce daily sitting time.
-
NT-proBNP–guided heart failure screening for people 65+ in rural China
This study tests whether using NT-proBNP blood tests to guide heart failure screening in adults 65 and older in rural China can find unrecognized heart problems more effectively than symptom-based screening.
-
Voice-based detection of heart failure deterioration using Noah Labs Vox
This study tests whether a voice-analysis app can flag worsening heart failure in adults by comparing its alerts to standard weight-based monitoring.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.